| Literature DB >> 31628011 |
Amy Inselman1, Fang Liu2, Cheng Wang2, Qiang Shi1, Li Pang1, William Mattes1, Matthew White3, Beverly Lyn-Cook4, Hector Rosas-Hernandez2, Elvis Cuevas2, Susan Lantz2, Syed Imam2, Syed Ali2, Dayton M Petibone5, Jennifer M Shemansky5, Rui Xiong5, Yiying Wang5, Priya Tripathi5, Xuefei Cao5, Robert H Heflich5, William Slikker6.
Abstract
For the past five years, Dr. Daniel Acosta has served as the Deputy Director of Research at the National Center for Toxicological Research (NCTR), a principle research laboratory of the U.S. Food and Drug Administration (FDA). Over his career at NCTR, Dr. Acosta has had a major impact on developing and promoting the use of in vitro assays in regulatory toxicity and product safety assessments. As Dr. Acosta nears his retirement we have dedicated this paper to his many accomplishments at the NCTR. Described within this paper are some of the in vitro studies that have been conducted under Dr. Acosta's leadership. These studies include toxicological assessments involving developmental effects, and the development and application of in vitro reproductive, heart, liver, neurological and airway cell and tissue models. Published by Elsevier Ltd.Entities:
Year: 2019 PMID: 31628011 DOI: 10.1016/j.tiv.2019.03.003
Source DB: PubMed Journal: Toxicol In Vitro ISSN: 0887-2333 Impact factor: 3.500